LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

ABBV

185.23

-2.89%↓

NVO

74.38

-3.34%↓

UNH

308.61

+0.35%↑

LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

ABBV

185.23

-2.89%↓

NVO

74.38

-3.34%↓

UNH

308.61

+0.35%↑

LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

ABBV

185.23

-2.89%↓

NVO

74.38

-3.34%↓

UNH

308.61

+0.35%↑

LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

ABBV

185.23

-2.89%↓

NVO

74.38

-3.34%↓

UNH

308.61

+0.35%↑

LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

ABBV

185.23

-2.89%↓

NVO

74.38

-3.34%↓

UNH

308.61

+0.35%↑

Search

AcelRx Pharmaceuticals Inc

Slēgts

0

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

Max

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+532.91% upside

AcelRx Pharmaceuticals Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 17. jūn. 14:44 UTC

Iegādes, apvienošanās, pārņemšana

Justice Department Orders Safran to Sell Assets to Proceed with Buy of Collins Aerospace Business

2025. g. 17. jūn. 23:43 UTC

Tirgus saruna

Nikkei May Fall Amid Uncertainty Over Israel-Iran Conflict -- Market Talk

2025. g. 17. jūn. 23:34 UTC

Tirgus saruna

Gold Steady, Underpinned by Ongoing Geopolitical Tensions -- Market Talk

2025. g. 17. jūn. 23:22 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 17. jūn. 23:22 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

2025. g. 17. jūn. 23:22 UTC

Tirgus saruna

Meridian Energy Set to Draw Line Under 'Annus Horribilis' -- Market Talk

2025. g. 17. jūn. 23:17 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Tourism Holdings Likely to Seek Higher Offer -- Market Talk

2025. g. 17. jūn. 23:05 UTC

Tirgus saruna

Fletcher Building Could Signal Improved Shareholder Returns -- Market Talk

2025. g. 17. jūn. 23:05 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 17. jūn. 22:58 UTC

Tirgus saruna

Australian Treasurer Chalmers Expected to Outline Second-Term Reform Agenda -- Market Talk

2025. g. 17. jūn. 22:55 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

XRG Has a Good Argument for Regulatory Approval of Santos Deal -- Market Talk

2025. g. 17. jūn. 22:31 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Lifeway Foods CEO Not Surprised by Takeover Interest -- Market Talk

2025. g. 17. jūn. 22:14 UTC

Galvenie tirgus virzītāji

Bitdeer Technologies Group Shares Fall on Note Offering

2025. g. 17. jūn. 19:49 UTC

Tirgus saruna

Natural Gas Slow Down Gains -- Market Talk

2025. g. 17. jūn. 19:34 UTC

Tirgus saruna

Oil Rises On Israel-Iran Conflict Uncertainty -- Market Talk

2025. g. 17. jūn. 19:10 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 17. jūn. 19:10 UTC

Tirgus saruna

Dollar Strengthens, Treasury Yields Fall in Risk-Off Trade -- Market Talk

2025. g. 17. jūn. 18:41 UTC

Tirgus saruna

Slowdown in US Consumer Spending Expected -- Market Talk

2025. g. 17. jūn. 18:15 UTC

Tirgus saruna

Gold Inches Down as Profit-Taking Seen -- Market Talk

2025. g. 17. jūn. 17:44 UTC

Tirgus saruna

Analysts Forecast Record-High Ethanol Output -- Market Talk

2025. g. 17. jūn. 16:37 UTC

Tirgus saruna

A Buy-Canadian Policy Could Support Steel Producers -- Market Talk

2025. g. 17. jūn. 16:30 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 17. jūn. 16:30 UTC

Tirgus saruna

Canada Seen Likely to Drop Digital-Services Tax -- Market Talk

2025. g. 17. jūn. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 17. jūn. 16:15 UTC

Tirgus saruna

Base Metal Prices Mixed on Risk-Off Sentiment -- Market Talk

2025. g. 17. jūn. 16:12 UTC

Tirgus saruna

Gold Futures Fall as Safe-haven Demand Retreats -- Market Talk

2025. g. 17. jūn. 14:54 UTC

Tirgus saruna

Oil Rises on Continued Israel-Iran Conflict -- Market Talk

2025. g. 17. jūn. 14:47 UTC

Tirgus saruna

European Gas Climbs on Middle East Risks, EU Russian Ban Proposal -- Market Talk

2025. g. 17. jūn. 14:41 UTC

Tirgus saruna

Natural Gas Extends Climb -- Market Talk

2025. g. 17. jūn. 14:40 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

AcelRx Pharmaceuticals Inc Prognoze

Cenas mērķis

By TipRanks

532.91% augšup

Prognoze 12 mēnešiem

Vidējais 5 USD  532.91%

Augstākais 5 USD

Zemākais 5 USD

Pamatojoties uz 1 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi AcelRx Pharmaceuticals Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

1 ratings

1

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

$